Copyright
©The Author(s) 2021.
World J Transplant. Dec 18, 2021; 11(12): 512-522
Published online Dec 18, 2021. doi: 10.5500/wjt.v11.i12.512
Published online Dec 18, 2021. doi: 10.5500/wjt.v11.i12.512
Patient | Usage time (d) | Reason for drug withdraw |
Patient 1 | > 180 | LTBI treatment complete |
Patient 2 | > 180 | LTBI treatment complete |
Patient 3 | > 180 | LTBI treatment complete |
Patient 4 | 57 | Changes in liver enzymes |
Patient 5 | 80 | Cholestasis |
Patient 6 | 93 | Clinical worsening - polyserositis |
Patient 7 | 112 | Not justified |
Patient 8 | 142 | Not justified |
Patient 9 | 146 | Not justified |
Patient 10 | 162 | Not justified |
Patient 11 | 171 | Not justified |
Patient 12 | 172 | Not justified |
- Citation: Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522
- URL: https://www.wjgnet.com/2220-3230/full/v11/i12/512.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i12.512